Biodesy Receives $10,000,000 Series B Round

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    384 Oyster Point Blvd. South San Francisco, CA 94080 USA
  • Company Description
    Biodesy has developed a unique and highly sensitive means of detecting conformational change in proteins and other biological molecules. Our technology, based on a phenomenon called ‘second-harmonic generation’ (SHG), can monitor structural change at any site within a protein, in real time.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series B
  • Proceeds Purposes
    Proceeds from the financing will be used to expand and accelerate commercialization of the Biodesy Delta System, a new, real-time, high-throughput platform that enables researchers to measure conformational change in their own laboratories.
  • M&A Terms
  • Venture Investor
    5AM Ventures
  • Venture Investor
    Pfizer Venture Investments
  • Venture Investor
    Roche Venture Fund

Trending on Xconomy